Related Experiment Video
Updated: Oct 23, 2025

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
Ivano Caselli1, Alessandra Gasparini1, Marta Ielmini1
1Caselli, MD, PhD Student, Gasparini, MD, PhD Student, Ielmini, MD, PhD Student, Lucca, MD, PhD Student, Amorosi, MD, Poloni, MD, PhD, Researcher, Callegari, MD, PhD, Associate Professor, Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, Varese, Italy.
Abstract:
Nowadays, mental illness can no longer be considered as a mere list of symptoms corresponding to localized brain dysfunctions but rather as a disturbance of the patient's subjectivity. Thus, a solid, qualitative study of patients' subjectivity could represent a useful tool in the complex evaluation of efficacy of pharmacotherapy in schizophrenic persons. In this perspective, authors performed a phenomenological oriented investigation on 49 patients, diagnosed with schizophrenia spectrum disorder, who were receiving long-acting injectable (LAI) antipsychotic therapy. From data analysis, authors found a positive correlation between general psychopathology and the use of LAI antipsychotic therapies. The present study highlighted the necessity of a careful investigation of patients' subjectivity in a phenomenological way as an irreducible part of both psychopathological and psychopharmacological matters.
Related Concept Videos
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Dosage Regimen: Individualization
Drug Accumulation During Multiple Dosing: Repetitive IV Injections

